NCT06715215 Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia Status RECRUITING Phase NA
NCT06577909 Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy Status RECRUITING Phase PHASE2
NCT06556888 Observatory of Immunological Thrombopenic Purpura in the Brest Region Status RECRUITING Phase N/A
NCT06519565 Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP) Status RECRUITING Phase EARLY_PHASE1
NCT06478537 TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination Status RECRUITING Phase PHASE2
NCT06444477 Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer Status COMPLETED Phase N/A
NCT06417398 Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06291415 The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) Status WITHDRAWN Phase PHASE1
NCT06287567 Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE2
NCT06281327 Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia Status RECRUITING Phase PHASE2
NCT06199089 A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06190145 Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia Status RECRUITING Phase PHASE2
NCT06176911 The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia Status RECRUITING Phase PHASE2
NCT06176235 Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia Status WITHDRAWN Phase PHASE2
NCT06168851 Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) Status RECRUITING Phase PHASE2
NCT06094881 A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) Status RECRUITING Phase PHASE2
NCT06073925 Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05995054 A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05937828 OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia Status RECRUITING Phase N/A
NCT05932524 Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia Status UNKNOWN Phase PHASE2